Twist Bioscience Corp’s filing revealed that its Officer Laponis Adam acquired Company’s shares for reported $88887.0 on Apr 09 ’25. In the deal valued at $34.97 per share,2,542 shares were bought.
Then, Cho Dennis sold 124 shares, generating $4,803 in total proceeds. Upon selling the shares at $38.73, the insider now owns 111,538 shares.
Before that, Finn Patrick John sold 206 shares. Twist Bioscience Corp shares valued at $7,979 were divested by the President and COO at a price of $38.73 per share. As a result of the transaction, Finn Patrick John now holds 267,518 shares, worth roughly $10.65 million.
Wolfe Research initiated its Twist Bioscience Corp [TWST] rating to an Outperform in a research note published on December 13, 2024; the price target was $60. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in early June with a ‘”a Buy”‘ rating. Goldman also remained covering TWST and has increased its forecast on January 17, 2024 with a “Buy” recommendation from previously “Neutral” rating. Berenberg started covering the stock on September 27, 2023. It rated TWST as “a Buy”.
Price Performance Review of TWST
On Monday, Twist Bioscience Corp [NASDAQ:TWST] saw its stock jump 2.50% to $39.82. Over the last five days, the stock has gained 7.65%. Twist Bioscience Corp shares have fallen nearly -14.31% since the year began. Nevertheless, the stocks have risen 21.85% over the past one year. While a 52-week high of $60.90 was reached on 01/24/25, a 52-week low of $27.41 was recorded on 04/07/25. SMA at 50 days reached $42.26, while 200 days put it at $45.58.
Levels Of Support And Resistance For TWST Stock
The 24-hour chart illustrates a support level at 38.82, which if violated will result in even more drops to 37.83. On the upside, there is a resistance level at 40.58. A further resistance level may holdings at 41.35. The Relative Strength Index (RSI) on the 14-day chart is 49.83, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.26, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 43.46%. Stochastics %K at 44.51% indicates the stock is a holding.
How much short interest is there in Twist Bioscience Corp?
A steep rise in short interest was recorded in Twist Bioscience Corp stocks on 2025-03-31, growing by 0.29 million shares to a total of 9.59 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 9.3 million shares. There was a rise of 3.06%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 05, 2023 when Scotiabank began covering the stock and recommended ‘”a Sector outperform”‘ rating along with a $33 price target.
